Novogene(SH:688315) Zheng Quan Zhi Xing·2025-09-01 12:19Group 1 - The legal opinion letter is issued by Beijing Zhonglun Law Firm regarding the legality of the 2025 first extraordinary general meeting of shareholders of Beijing Novogene Bioinformatics Technology Co., Ltd [1][2] - The law firm confirms that it has reviewed the necessary documents and materials provided by the company for the issuance of the legal opinion [2][4] - The legal opinion focuses on the convening, holding procedures, qualifications of attendees, and voting procedures of the shareholders' meeting, without commenting on the content of the proposals discussed [4][9] Group 2 - The notice for the shareholders' meeting was properly communicated to all shareholders, including details on time, location, agenda, and registration methods [5][6] - The meeting was held at Novogene Building, with the chairman presiding, and voting was conducted both on-site and via an online platform [6][9] - A total of 2 shareholders attended the meeting in person, representing 214,810,348 shares, and 61 shareholders participated through online voting [6][7] Group 3 - The voting results showed that 218,029,592 shares were in favor of the proposals, with a small number of shares abstaining [9] - The law firm concludes that the convening, holding procedures, qualifications of attendees, and voting results of the shareholders' meeting are all in compliance with relevant laws and regulations [9]